4//SEC Filing
Barrett Elizabeth A. 4
Accession 0001209191-22-006383
CIK 0001668243other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:32 PM ET
Size
16.7 KB
Accession
0001209191-22-006383
Insider Transaction Report
Form 4
Barrett Elizabeth A.
Chief Executive Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-01-31−13,333→ 26,667 total→ Ordinary Shares (13,333 underlying) - Exercise/Conversion
Ordinary Shares
2022-01-31+13,333→ 314,318 total - Exercise/Conversion
Restricted Stock Units
2022-01-31−5,000→ 5,000 total→ Ordinary Shares (5,000 underlying) - Exercise/Conversion
Ordinary Shares
2022-01-31+5,000→ 303,220 total - Sale
Ordinary Shares
2022-01-31$7.58/sh−2,235$16,941→ 300,985 total - Sale
Ordinary Shares
2022-01-31$7.58/sh−5,960$45,177→ 308,358 total - Award
Stock Option (right to buy)
2022-01-31+150,000→ 150,000 totalExercise: $7.72Exp: 2032-01-31→ Ordinary Shares (150,000 underlying)
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
- [F2]Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units
- [F3]The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021.
- [F4]The reporting person was granted restricted stock units ("RSUs") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022.
- [F5]1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001764157
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:32 PM ET
- Size
- 16.7 KB